Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), Region - Global Forecast to 2028
The global smart pills market is projected to reach USD 1.1 billion by 2028 from USD 0.6 billion in 2023, at a CAGR of 11.8% during the forecast period. Growth in this market is majorly driven by the rise in demand for non-invasive diagnostic monitoring devices, technological advancements in capsule endoscopy and significant advancements in capsule endoscopy technology. The growing demand for advanced drug delivery systems and need for a rapid drug development process are expected to offer opportunities for market players during the forecast period. On the other hand, technological incompetence of smart pills in some conditions is expected to restrain the market growth to some extent in the coming years
“The vital sign monitoring segment is projected to grow at the highest CAGR during the forecast period.”
Based on application, the market for smart pills is divided into segments for target drug devliery, capsule endoscopy, and vital sign monitoring. The vital sign monitoring segments is projected to grow at the highest CAGR during the forecast period. This is due to the increasing need for precise and accurate measurement of inner body temperature and insufficient integration with digital health systems in conventional vital sign monitoring devices. As healthcare systems strive for interoperability and comprehensive patient records, the rising need for vital sign monitoring devices that integrate smoothly with digital health systems becomes crucial. The growing demand for streamlined integration is expected to increase the adoption of smart pills due to advanced connectivity and compatibility with digital health systems.
“The large intestine target area accounted for the second largest share of the market during the forecast period. “
Based on target area, the smart pills market is broadly segmented into, small intestine, large intestine, esophagus, and stomach. The large intestine target area accounted for the second largest share in 2022 and this is attributed to the increasing cases of colorectal cancer and need for effective screening, diagnosis, and monitoring of inflammatory bowel diseases and other gastrointestinal disorders. The increasing cases of colorectal cancer have contributed to the growing adoption of smart pills in large intestine as smart pills can reach areas of the colon that may be challenging to visualize with traditional methods.
The diagnostic centers segment accounted for the second largest share of the market in 2022
Based on end users, the smart pills market is broadly segmented into diagnostic centers, hospitals, and other end users. Diagnostic centers are the second largest end users of the smart pills market. This can be attributed to the advancements in technology, demand for non-invasive diagnostics, and improved diagnostic accuracy. The integration of smart pills in diagnostic centers has been a key factor in driving utilization by offering expanded diagnostic capabilities, enhanced patient experience, improved operational efficiency, and the ability to facilitate remote diagnostics.
Europe accounted for the second largest share of the smart pills market in 2022
In 2022, Europe accounted for the second largest share of the smart pills market. This can be attributed to factors such as growth in ageing population and increased utilization of capsule endoscopy for gastrointestinal bleeding. The endorsement of capsule endoscopy by the European Society of Gastrointestinal Endoscopy (ESGE) guidelines provides a standardized approach for healthcare professionals, enhancing the quality of care provided to patients. As a result, there is a growing demand for smart pills and related technologies, driven by the increased utilization of capsule endoscopy for gastrointestinal bleeding.
The break up of the profile of primary participants in the smart pills market:
The key players operating in the smart pills market include RF Co., Ltd (Japan), etectrx(US), Olympus Corporation (Japan), BodyCap (France), Chongqing Jinshan Science Technology (Group) Co., Ltd (China), Check-Cap Ltd. (Israel), CapsoVision,Inc. (US), ANX Robotica Corp. (US), Medtronic plc (US), IntroMedic (South Korea), Shenzen Jifu Medical Technology Co., Ltd (China) and Otsuka America Pharmaceutical, Inc. (US).
Research Coverage:
The report analyzes the smart pills market and aims at estimating the market size and future growth potential of this market based on various segments such as application, target area, and end user. The report also includes a product portfolio matrix of various smart pills products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
“The vital sign monitoring segment is projected to grow at the highest CAGR during the forecast period.”
Based on application, the market for smart pills is divided into segments for target drug devliery, capsule endoscopy, and vital sign monitoring. The vital sign monitoring segments is projected to grow at the highest CAGR during the forecast period. This is due to the increasing need for precise and accurate measurement of inner body temperature and insufficient integration with digital health systems in conventional vital sign monitoring devices. As healthcare systems strive for interoperability and comprehensive patient records, the rising need for vital sign monitoring devices that integrate smoothly with digital health systems becomes crucial. The growing demand for streamlined integration is expected to increase the adoption of smart pills due to advanced connectivity and compatibility with digital health systems.
“The large intestine target area accounted for the second largest share of the market during the forecast period. “
Based on target area, the smart pills market is broadly segmented into, small intestine, large intestine, esophagus, and stomach. The large intestine target area accounted for the second largest share in 2022 and this is attributed to the increasing cases of colorectal cancer and need for effective screening, diagnosis, and monitoring of inflammatory bowel diseases and other gastrointestinal disorders. The increasing cases of colorectal cancer have contributed to the growing adoption of smart pills in large intestine as smart pills can reach areas of the colon that may be challenging to visualize with traditional methods.
The diagnostic centers segment accounted for the second largest share of the market in 2022
Based on end users, the smart pills market is broadly segmented into diagnostic centers, hospitals, and other end users. Diagnostic centers are the second largest end users of the smart pills market. This can be attributed to the advancements in technology, demand for non-invasive diagnostics, and improved diagnostic accuracy. The integration of smart pills in diagnostic centers has been a key factor in driving utilization by offering expanded diagnostic capabilities, enhanced patient experience, improved operational efficiency, and the ability to facilitate remote diagnostics.
Europe accounted for the second largest share of the smart pills market in 2022
In 2022, Europe accounted for the second largest share of the smart pills market. This can be attributed to factors such as growth in ageing population and increased utilization of capsule endoscopy for gastrointestinal bleeding. The endorsement of capsule endoscopy by the European Society of Gastrointestinal Endoscopy (ESGE) guidelines provides a standardized approach for healthcare professionals, enhancing the quality of care provided to patients. As a result, there is a growing demand for smart pills and related technologies, driven by the increased utilization of capsule endoscopy for gastrointestinal bleeding.
The break up of the profile of primary participants in the smart pills market:
- By Company Type: Tier 1- 60%, Tier 2- 30%, and Tier 3-10%
- By Designation: C-level Executives- 50%, Directors- 40% , and Others- 10%.
- By Region: North America- 45%, Europe- 35%, Asia Pacific- 15%, and Rest of the World- 5%.
The key players operating in the smart pills market include RF Co., Ltd (Japan), etectrx(US), Olympus Corporation (Japan), BodyCap (France), Chongqing Jinshan Science Technology (Group) Co., Ltd (China), Check-Cap Ltd. (Israel), CapsoVision,Inc. (US), ANX Robotica Corp. (US), Medtronic plc (US), IntroMedic (South Korea), Shenzen Jifu Medical Technology Co., Ltd (China) and Otsuka America Pharmaceutical, Inc. (US).
Research Coverage:
The report analyzes the smart pills market and aims at estimating the market size and future growth potential of this market based on various segments such as application, target area, and end user. The report also includes a product portfolio matrix of various smart pills products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global smart pills market. The report analyzes this market by applications, target area and end user.
- Service Enhancement/Innovation: Detailed insights on upcoming trends in the global smart pills market
- Market Development: Comprehensive information on the lucrative emerging markets by applications, target area and end user.
- Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global smart pills market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global smart pills market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 SMART PILLS MARKET: MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.3 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 SMART PILLS MARKET: SEGMENTAL EXTRAPOLATION
FIGURE 7 SMART PILLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION METHODOLOGY
FIGURE 9 SMART PILLS MARKET: DATA TRIANGULATION METHODOLOGY
2.3 MARKET SHARE ANALYSIS
2.4 STUDY ASSUMPTIONS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 SMART PILLS MARKET: RISK ASSESSMENT ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 SMART PILLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 SMART PILLS MARKET, BY TARGET AREA, 2023 VS. 2028 (USD MILLION)
FIGURE 12 SMART PILLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF SMART PILLS MARKET
4 PREMIUM INSIGHTS
4.1 SMART PILLS MARKET OVERVIEW
FIGURE 14 RISING TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES TO DRIVE MARKET
4.2 NORTH AMERICA: SMART PILLS MARKET, BY END USER AND COUNTRY
FIGURE 15 HOSPITALS ACCOUNTED FOR LARGEST MARKET SHARE IN US FOR 2022
4.3 SMART PILLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 SMART PILLS MARKET: REGIONAL MIX
FIGURE 17 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.5 SMART PILLS MARKET: DEVELOPING VS. EMERGING MARKETS
FIGURE 18 EMERGING MARKETS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 SMART PILLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 SMART PILLS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising demand for noninvasive diagnostic monitoring devices
5.2.1.2 Technological advancements in capsule endoscopy
5.2.1.3 Increasing incidence of colon cancer
5.2.2 RESTRAINTS
5.2.2.1 High costs
5.2.2.2 Technical limitations associated with accuracy of smart pills
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for advanced drug delivery systems
5.2.3.2 Rising need for rapid drug delivery development
5.2.4 CHALLENGES
5.2.4.1 Patient privacy concerns
5.3 INDUSTRY TRENDS
5.3.1 ADVANCEMENTS IN SENSOR TECHNOLOGY
5.3.2 INTEGRATION WITH WEARABLE DEVICES
5.4 TECHNOLOGY ANALYSIS
5.4.1 SELF-POWERED INGESTIBLE SMART PILL
5.4.2 ADAPTIVE FRAME RATE TECHNOLOGY
5.4.3 IMAG (INGESTIBLE MICRODEVICES FOR ANATOMIC MAPPING OF GASTROINTESTINAL TRACT)
TABLE 3 SENSOR AND BATTERY TYPES USED FOR CAPSULE ENDOSCOPY PRODUCTS
TABLE 4 SENSOR USED FOR VITAL SIGN MONITORING AND DRUG INGESTION TRACKING PRODUCTS
TABLE 5 SMART PILLS MARKET: DRUGS UNDER PIPELINE
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 ECOSYSTEM ANALYSIS
FIGURE 20 SMART PILLS MARKET: ECOSYSTEM ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 21 SMART PILLS MARKET: VALUE CHAIN ANALYSIS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR SMART PILLS
FIGURE 22 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2022)
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 23 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR SMART PILLS PATENTS (JANUARY 2012–DECEMBER 2022)
FIGURE 24 TOP APPLICANTS FOR SMART PILLS PATENTS (COUNTRY/REGION) (JANUARY 2012–JANUARY 2022)
TABLE 7 SMART PILLS MARKET: LIST OF PATENTS (2020–2023)
5.9 PRICING ANALYSIS
TABLE 8 PRICE RANGE FOR SMART PILLS (2022)
5.10 KEY CONFERENCES AND EVENTS
TABLE 9 SMART PILLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
5.11 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 REGULATORY ANALYSIS
5.12.1 NORTH AMERICA
5.12.1.1 US
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.12.3.2 China
TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION
TABLE 16 KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION
6 SMART PILLS MARKET, BY TARGET AREA
6.1 INTRODUCTION
TABLE 17 SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
6.2 SMALL INTESTINE
6.2.1 RISING INCIDENCE OF SMALL INTESTINE DISORDERS TO DRIVE MARKET
TABLE 18 SMART PILLS MARKET FOR SMALL INTESTINE, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 LARGE INTESTINE
6.3.1 INCREASING INCIDENCE OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH
TABLE 19 SMART PILLS MARKET FOR LARGE INTESTINE, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 ESOPHAGUS
6.4.1 EVALUATION AND MONITORING OF BARRETT’S ESOPHAGUS TO PROPEL MARKET
TABLE 20 SMART PILLS MARKET FOR ESOPHAGUS, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 STOMACH
6.5.1 IMPROVED DIAGNOSTIC ACCURACY TO SUPPORT MARKET GROWTH
TABLE 21 SMART PILLS MARKET FOR STOMACH, BY COUNTRY, 2021–2028 (USD MILLION)
7 SMART PILLS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 22 SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 CAPSULE ENDOSCOPY
7.2.1 ABILITY TO ASSESS GASTROINTESTINAL BLEEDING AND SMALL-BOWL TUMORS TO DRIVE MARKET
TABLE 23 CAPSULE ENDOSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 24 SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 VITAL SIGN MONITORING
7.3.1 LAUNCH OF INNOVATIVE SENSOR TECHNOLOGIES TO PROPEL MARKET
TABLE 25 VITAL SIGN MONITORING SMART PILLS UNDER PIPELINE
TABLE 26 SMART PILLS MARKET FOR VITAL SIGN MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 TARGETED DRUG DELIVERY
7.4.1 SITE-SPECIFIC DRUG DELIVERY INTEGRATION WITH SMART PILLS TO SUPPORT MARKET GROWTH
TABLE 27 TARGETED DRUG DELIVERY SMART PILLS UNDER PIPELINE
TABLE 28 SMART PILLS MARKET FOR TARGETED DRUG DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)
8 SMART PILLS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 29 SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 RISING NEED FOR TECHNOLOGICALLY ADVANCED ENDOSCOPY PROCEDURES TO DRIVE MARKET
TABLE 30 SMART PILLS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC CENTERS
8.3.1 GROWING PREFERENCE FOR NONINVASIVE DIAGNOSTICS TO PROPEL MARKET
TABLE 31 SMART PILLS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 OTHER END USERS
TABLE 32 SMART PILLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 SMART PILLS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 33 SMART PILLS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 CAPSULE ENDOSCOPY MARKET, BY REGION, 2021–2028 (MILLION UNITS)
TABLE 35 VITAL SIGN MONITORING MARKET, BY REGION, 2021–2028 (MILLION UNITS)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: SMART PILLS MARKET SNAPSHOT
TABLE 36 NORTH AMERICA: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 NORTH AMERICA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 Favorable reimbursements for endoscopy procedures to drive market
TABLE 40 US: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 41 US: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 42 US: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising incidence of IBD to drive market
TABLE 43 CANADA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 44 CANADA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 45 CANADA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
TABLE 46 EUROPE: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising incidence of Chron’s disease to drive market
TABLE 50 GERMANY: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 51 GERMANY: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 52 GERMANY: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Utilization of capsule endoscopy for bowel cancer to drive market
TABLE 53 UK: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 54 UK: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 55 UK: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Reimbursement coverage for small bowel capsule endoscopy to drive market
TABLE 56 FRANCE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 57 FRANCE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 58 FRANCE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising adoption of technologically advanced endoscopes to support market growth
TABLE 59 ITALY: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 60 ITALY: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 61 ITALY: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 REST OF EUROPE
TABLE 62 REST OF EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 63 REST OF EUROPE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 64 REST OF EUROPE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: SMART PILLS MARKET SNAPSHOT
TABLE 65 ASIA PACIFIC: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Rising incidence of gastric cancer to drive market
TABLE 69 JAPAN: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 70 JAPAN: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 71 JAPAN: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Increasing funding initiatives for development of smart pills to fuel market
TABLE 72 CHINA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 73 CHINA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 74 CHINA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising incidence of IBD to support market growth
TABLE 75 INDIA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 76 INDIA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 77 INDIA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 78 REST OF ASIA PACIFIC: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 79 REST OF ASIA PACIFIC: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 80 REST OF ASIA PACIFIC: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 ASIA PACIFIC: RECESSION IMPACT
9.5 REST OF THE WORLD
TABLE 81 REST OF THE WORLD: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 82 REST OF THE WORLD: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 83 REST OF THE WORLD: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 84 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
10.2.1 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE SHARE ANALYSIS OF LEADING PLAYERS
10.2.2 MARKET SHARE ANALYSIS
FIGURE 30 SMART PILLS MARKET SHARE, BY KEY PLAYER (2022)
10.3 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PERVASIVE PLAYERS
10.3.4 PARTICIPANTS
FIGURE 31 SMART PILLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
10.4 COMPANY FOOTPRINT ANALYSIS
TABLE 85 SMART PILLS MARKET: COMPANY FOOTPRINT ANALYSIS
10.4.1 APPLICATION FOOTPRINT ANALYSIS
TABLE 86 SMART PILLS MARKET: APPLICATION FOOTPRINT
10.4.2 TARGET AREA FOOTPRINT ANALYSIS
TABLE 87 SMART PILLS MARKET: TARGET AREA FOOTPRINT
10.4.3 END USER FOOTPRINT ANALYSIS
TABLE 88 SMART PILLS MARKET: END USER FOOTPRINT
10.4.4 REGIONAL FOOTPRINT ANALYSIS
TABLE 89 SMART PILLS MARKET: REGIONAL FOOTPRINT
10.5 COMPETITIVE SCENARIO
10.5.1 PRODUCT LAUNCHES & APPROVALS
TABLE 90 SMART PILLS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–JUNE 2023)
10.5.2 DEALS
TABLE 91 SMART PILLS MARKET: DEALS (JANUARY 2020–JUNE 2023)
10.5.3 OTHER DEVELOPMENTS
TABLE 92 SMART PILLS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–JUNE 2023)
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
TABLE 93 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 32 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.2 CAPSOVISION, INC.
TABLE 94 CAPSOVISION, INC.: BUSINESS OVERVIEW
11.1.3 MEDTRONIC PLC
TABLE 95 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
11.1.4 INTROMEDIC
TABLE 96 INTROMEDIC: BUSINESS OVERVIEW
11.1.5 ANX ROBOTICA CORP.
TABLE 97 ANX ROBOTICA CORP.: BUSINESS OVERVIEW
11.1.6 SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.
TABLE 98 SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
11.1.7 CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.
TABLE 99 CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.: BUSINESS OVERVIEW
11.1.8 RF CO., LTD.
TABLE 100 RF CO., LTD.: BUSINESS OVERVIEW
11.1.9 ETECTRX
TABLE 101 ETECTRX: BUSINESS OVERVIEW
11.1.10 BODYCAP
TABLE 102 BODYCAP: BUSINESS OVERVIEW
11.1.11 OTSUKA AMERICA PHARMACEUTICAL, INC.
TABLE 103 OTSUKA AMERICA PHARMACEUTICAL, INC.: BUSINESS OVERVIEW
11.1.12 CHECK-CAP LTD.
TABLE 104 CHECK-CAP LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 SMART PILLS MARKET: MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.3 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 SMART PILLS MARKET: SEGMENTAL EXTRAPOLATION
FIGURE 7 SMART PILLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION METHODOLOGY
FIGURE 9 SMART PILLS MARKET: DATA TRIANGULATION METHODOLOGY
2.3 MARKET SHARE ANALYSIS
2.4 STUDY ASSUMPTIONS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 SMART PILLS MARKET: RISK ASSESSMENT ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 SMART PILLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 SMART PILLS MARKET, BY TARGET AREA, 2023 VS. 2028 (USD MILLION)
FIGURE 12 SMART PILLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF SMART PILLS MARKET
4 PREMIUM INSIGHTS
4.1 SMART PILLS MARKET OVERVIEW
FIGURE 14 RISING TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES TO DRIVE MARKET
4.2 NORTH AMERICA: SMART PILLS MARKET, BY END USER AND COUNTRY
FIGURE 15 HOSPITALS ACCOUNTED FOR LARGEST MARKET SHARE IN US FOR 2022
4.3 SMART PILLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 SMART PILLS MARKET: REGIONAL MIX
FIGURE 17 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.5 SMART PILLS MARKET: DEVELOPING VS. EMERGING MARKETS
FIGURE 18 EMERGING MARKETS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 SMART PILLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 SMART PILLS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising demand for noninvasive diagnostic monitoring devices
5.2.1.2 Technological advancements in capsule endoscopy
5.2.1.3 Increasing incidence of colon cancer
5.2.2 RESTRAINTS
5.2.2.1 High costs
5.2.2.2 Technical limitations associated with accuracy of smart pills
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for advanced drug delivery systems
5.2.3.2 Rising need for rapid drug delivery development
5.2.4 CHALLENGES
5.2.4.1 Patient privacy concerns
5.3 INDUSTRY TRENDS
5.3.1 ADVANCEMENTS IN SENSOR TECHNOLOGY
5.3.2 INTEGRATION WITH WEARABLE DEVICES
5.4 TECHNOLOGY ANALYSIS
5.4.1 SELF-POWERED INGESTIBLE SMART PILL
5.4.2 ADAPTIVE FRAME RATE TECHNOLOGY
5.4.3 IMAG (INGESTIBLE MICRODEVICES FOR ANATOMIC MAPPING OF GASTROINTESTINAL TRACT)
TABLE 3 SENSOR AND BATTERY TYPES USED FOR CAPSULE ENDOSCOPY PRODUCTS
TABLE 4 SENSOR USED FOR VITAL SIGN MONITORING AND DRUG INGESTION TRACKING PRODUCTS
TABLE 5 SMART PILLS MARKET: DRUGS UNDER PIPELINE
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 ECOSYSTEM ANALYSIS
FIGURE 20 SMART PILLS MARKET: ECOSYSTEM ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 21 SMART PILLS MARKET: VALUE CHAIN ANALYSIS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR SMART PILLS
FIGURE 22 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2022)
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 23 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR SMART PILLS PATENTS (JANUARY 2012–DECEMBER 2022)
FIGURE 24 TOP APPLICANTS FOR SMART PILLS PATENTS (COUNTRY/REGION) (JANUARY 2012–JANUARY 2022)
TABLE 7 SMART PILLS MARKET: LIST OF PATENTS (2020–2023)
5.9 PRICING ANALYSIS
TABLE 8 PRICE RANGE FOR SMART PILLS (2022)
5.10 KEY CONFERENCES AND EVENTS
TABLE 9 SMART PILLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
5.11 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 REGULATORY ANALYSIS
5.12.1 NORTH AMERICA
5.12.1.1 US
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.12.3.2 China
TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION
TABLE 16 KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION
6 SMART PILLS MARKET, BY TARGET AREA
6.1 INTRODUCTION
TABLE 17 SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
6.2 SMALL INTESTINE
6.2.1 RISING INCIDENCE OF SMALL INTESTINE DISORDERS TO DRIVE MARKET
TABLE 18 SMART PILLS MARKET FOR SMALL INTESTINE, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 LARGE INTESTINE
6.3.1 INCREASING INCIDENCE OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH
TABLE 19 SMART PILLS MARKET FOR LARGE INTESTINE, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 ESOPHAGUS
6.4.1 EVALUATION AND MONITORING OF BARRETT’S ESOPHAGUS TO PROPEL MARKET
TABLE 20 SMART PILLS MARKET FOR ESOPHAGUS, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 STOMACH
6.5.1 IMPROVED DIAGNOSTIC ACCURACY TO SUPPORT MARKET GROWTH
TABLE 21 SMART PILLS MARKET FOR STOMACH, BY COUNTRY, 2021–2028 (USD MILLION)
7 SMART PILLS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 22 SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 CAPSULE ENDOSCOPY
7.2.1 ABILITY TO ASSESS GASTROINTESTINAL BLEEDING AND SMALL-BOWL TUMORS TO DRIVE MARKET
TABLE 23 CAPSULE ENDOSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 24 SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 VITAL SIGN MONITORING
7.3.1 LAUNCH OF INNOVATIVE SENSOR TECHNOLOGIES TO PROPEL MARKET
TABLE 25 VITAL SIGN MONITORING SMART PILLS UNDER PIPELINE
TABLE 26 SMART PILLS MARKET FOR VITAL SIGN MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 TARGETED DRUG DELIVERY
7.4.1 SITE-SPECIFIC DRUG DELIVERY INTEGRATION WITH SMART PILLS TO SUPPORT MARKET GROWTH
TABLE 27 TARGETED DRUG DELIVERY SMART PILLS UNDER PIPELINE
TABLE 28 SMART PILLS MARKET FOR TARGETED DRUG DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)
8 SMART PILLS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 29 SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 RISING NEED FOR TECHNOLOGICALLY ADVANCED ENDOSCOPY PROCEDURES TO DRIVE MARKET
TABLE 30 SMART PILLS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC CENTERS
8.3.1 GROWING PREFERENCE FOR NONINVASIVE DIAGNOSTICS TO PROPEL MARKET
TABLE 31 SMART PILLS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 OTHER END USERS
TABLE 32 SMART PILLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 SMART PILLS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 33 SMART PILLS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 CAPSULE ENDOSCOPY MARKET, BY REGION, 2021–2028 (MILLION UNITS)
TABLE 35 VITAL SIGN MONITORING MARKET, BY REGION, 2021–2028 (MILLION UNITS)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: SMART PILLS MARKET SNAPSHOT
TABLE 36 NORTH AMERICA: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 NORTH AMERICA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 Favorable reimbursements for endoscopy procedures to drive market
TABLE 40 US: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 41 US: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 42 US: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising incidence of IBD to drive market
TABLE 43 CANADA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 44 CANADA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 45 CANADA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
TABLE 46 EUROPE: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising incidence of Chron’s disease to drive market
TABLE 50 GERMANY: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 51 GERMANY: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 52 GERMANY: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Utilization of capsule endoscopy for bowel cancer to drive market
TABLE 53 UK: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 54 UK: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 55 UK: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Reimbursement coverage for small bowel capsule endoscopy to drive market
TABLE 56 FRANCE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 57 FRANCE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 58 FRANCE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising adoption of technologically advanced endoscopes to support market growth
TABLE 59 ITALY: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 60 ITALY: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 61 ITALY: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 REST OF EUROPE
TABLE 62 REST OF EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 63 REST OF EUROPE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 64 REST OF EUROPE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: SMART PILLS MARKET SNAPSHOT
TABLE 65 ASIA PACIFIC: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Rising incidence of gastric cancer to drive market
TABLE 69 JAPAN: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 70 JAPAN: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 71 JAPAN: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Increasing funding initiatives for development of smart pills to fuel market
TABLE 72 CHINA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 73 CHINA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 74 CHINA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising incidence of IBD to support market growth
TABLE 75 INDIA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 76 INDIA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 77 INDIA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 78 REST OF ASIA PACIFIC: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 79 REST OF ASIA PACIFIC: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 80 REST OF ASIA PACIFIC: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 ASIA PACIFIC: RECESSION IMPACT
9.5 REST OF THE WORLD
TABLE 81 REST OF THE WORLD: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 82 REST OF THE WORLD: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)
TABLE 83 REST OF THE WORLD: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 84 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
10.2.1 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE SHARE ANALYSIS OF LEADING PLAYERS
10.2.2 MARKET SHARE ANALYSIS
FIGURE 30 SMART PILLS MARKET SHARE, BY KEY PLAYER (2022)
10.3 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PERVASIVE PLAYERS
10.3.4 PARTICIPANTS
FIGURE 31 SMART PILLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
10.4 COMPANY FOOTPRINT ANALYSIS
TABLE 85 SMART PILLS MARKET: COMPANY FOOTPRINT ANALYSIS
10.4.1 APPLICATION FOOTPRINT ANALYSIS
TABLE 86 SMART PILLS MARKET: APPLICATION FOOTPRINT
10.4.2 TARGET AREA FOOTPRINT ANALYSIS
TABLE 87 SMART PILLS MARKET: TARGET AREA FOOTPRINT
10.4.3 END USER FOOTPRINT ANALYSIS
TABLE 88 SMART PILLS MARKET: END USER FOOTPRINT
10.4.4 REGIONAL FOOTPRINT ANALYSIS
TABLE 89 SMART PILLS MARKET: REGIONAL FOOTPRINT
10.5 COMPETITIVE SCENARIO
10.5.1 PRODUCT LAUNCHES & APPROVALS
TABLE 90 SMART PILLS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–JUNE 2023)
10.5.2 DEALS
TABLE 91 SMART PILLS MARKET: DEALS (JANUARY 2020–JUNE 2023)
10.5.3 OTHER DEVELOPMENTS
TABLE 92 SMART PILLS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–JUNE 2023)
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
TABLE 93 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 32 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.2 CAPSOVISION, INC.
TABLE 94 CAPSOVISION, INC.: BUSINESS OVERVIEW
11.1.3 MEDTRONIC PLC
TABLE 95 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
11.1.4 INTROMEDIC
TABLE 96 INTROMEDIC: BUSINESS OVERVIEW
11.1.5 ANX ROBOTICA CORP.
TABLE 97 ANX ROBOTICA CORP.: BUSINESS OVERVIEW
11.1.6 SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.
TABLE 98 SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
11.1.7 CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.
TABLE 99 CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.: BUSINESS OVERVIEW
11.1.8 RF CO., LTD.
TABLE 100 RF CO., LTD.: BUSINESS OVERVIEW
11.1.9 ETECTRX
TABLE 101 ETECTRX: BUSINESS OVERVIEW
11.1.10 BODYCAP
TABLE 102 BODYCAP: BUSINESS OVERVIEW
11.1.11 OTSUKA AMERICA PHARMACEUTICAL, INC.
TABLE 103 OTSUKA AMERICA PHARMACEUTICAL, INC.: BUSINESS OVERVIEW
11.1.12 CHECK-CAP LTD.
TABLE 104 CHECK-CAP LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
